Focusing on oligomeric tau as a therapeutic target in Alzheimer’s disease and other tauopathies
Article in Expert Opinion on Therapeutic Targets (May 2023)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Immunotherapy with Cleavage-Specific 12A12mAb Reduces the Tau Cleavage in Visual Cortex and Improves Visuo-Spatial Recognition Memory in Tg2576 AD Mouse Model
Article in Pharmaceutics (February 2023)
Tau regulates Arc stability in neuronal dendrites via a proteasome-sensitive but ubiquitin-independent pathway
Preprint in bioRxiv (December 2022)